Autor: |
Takahiro Oike, Naoto Osu, Yuya Yoshimoto, Hideru Obinata, Kazuhiro Yoshikawa, Curtis C. Harris, Tatsuya Ohno |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Heliyon, Vol 9, Iss 6, Pp e16684- (2023) |
Druh dokumentu: |
article |
ISSN: |
2405-8440 |
DOI: |
10.1016/j.heliyon.2023.e16684 |
Popis: |
This pilot study aimed primarily to evaluate plasma levels of a novel metabolite, creatine riboside, in patients with cervical cancer (discovery and validation cohorts, n = 11 for each) compared with non-cancer subjects (controls, n = 30). We found that the pre-treatment plasma creatine riboside level was significantly higher in the discovery cohort than in controls. The cut-off value determined from the discovery cohort distinguished 90.9% of the patients in the validation cohort from controls. Unbiased principal component analysis of plasma metabolites in high-creatine riboside samples demonstrated enrichment of pathways involved in arginine and creatine metabolism. These data indicate the potential utility of plasma creatine riboside as a biomarker of cervical cancer. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|